N-3 pufa status predicts non-alcoholic fatty liver disease (NAFLD) in older Australians

N-3 pufa status predicts non-alcoholic fatty liver disease (NAFLD) in older Australians

Bibliographic Details
Main Authors:	M. Rose, M. Veysey, M. Lucock, S. Niblett, K. King, S. Baines, M.L. Garg
Format:	Article
Language:	English
Published:	Elsevier 2014-12-01
Series:	Journal of Nutrition & Intermediary Metabolism
Online Access:	http://www.sciencedirect.com/science/article/pii/S235238591400022X

Similar Items

N-3 pufa status is inversely associated with type 2 diabetes mellitus in older Australians
by: K. Abbott, et al.
Published: (2014-12-01)

Erythrocyte n-3pufa levels predict inflammatory status in older australians
by: M. Olliver, et al.
Published: (2014-12-01)

Erythrocyte long chain n-3 pufa level is a predictor of body weight status in older Australians
by: E. Mingay, et al.
Published: (2014-12-01)

Association between n-3 PUFA and blood lipid profile in older Australians
by: J. Drever, et al.
Published: (2014-12-01)

Association between erythrocyte omega-3 polyunsaturated fatty acid levels and fatty liver index in older people is sex dependent
by: Meagan Rose, et al.
Published: (2016-09-01)

Erythrocyte omega-3 polyunsaturated fatty acid levels are associated with biomarkers of inflammation in older Australians
by: Melinda Olliver, et al.
Published: (2016-09-01)

Sex-dependent association between omega-3 index and body weight status in older Australians
by: Edwina Mingay, et al.
Published: (2016-09-01)

Non-Alcoholic Fatty Liver Disease (NAFLD) in Obesity
by: Rushad Patell, et al.
Published: (2014-01-01)

Irisin Is Related to Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Marcin Kosmalski, et al.
Published: (2022-09-01)

Nutritional Management in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Sepideh Mahboobi, et al.
Published: (2015-07-01)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
by: Li Rong, et al.
Published: (2023-01-01)

The importance of the fatty acid transporter L-carnitine in non-alcoholic fatty liver disease (NAFLD)
by: Savic, D, et al.
Published: (2020)

Nonalcoholic fatty liver disease (NAFLD) among older adults
by: Panyavee Pitisuttithum, et al.
Published: (2022-12-01)

Probiotics as Potential Therapy in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Margalida Monserrat-Mesquida, et al.
Published: (2023-04-01)

Reduced plasma homocysteine levels in elderly Australians following mandatory folic acid fortification – A comparison of two cross-sectional cohorts
by: Emma Louise Beckett, et al.
Published: (2017-06-01)

Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: David Carneros, et al.
Published: (2020-11-01)

What’s New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Marcin Kosmalski, et al.
Published: (2023-02-01)

Effect of mediterranean diet on non-alcoholic fatty liver disease (NAFLD)
by: Patrycja Walczak, et al.
Published: (2023-01-01)

Non Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure
by: Alabagi Abdulla, et al.
Published: (2016-04-01)

Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD)
by: Adnan Khan, et al.
Published: (2022-10-01)

Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
by: Suneth Buddhika Agampodi, et al.
Published: (2022-12-01)

A TAS2R38 genotype dependent response to mandatory folic acid fortification: A comparison of two elderly cohorts
by: E.L. Beckett, et al.
Published: (2017-06-01)

The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Dragana Savic, et al.
Published: (2020-07-01)

Terpenoids: Natural Compounds for Non-Alcoholic Fatty Liver Disease (NAFLD) Therapy
by: Pengyu Yao, et al.
Published: (2022-12-01)

Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity
by: Saumya Madushani Samarasinghe, et al.
Published: (2023-08-01)

The Role of Resolvins, Protectins and Marensins in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Dominika Maciejewska-Markiewicz, et al.
Published: (2021-06-01)

Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences
by: Armando Tripodi, et al.
Published: (2022-01-01)

The effect of Ramadan fasting on non-alcoholic fatty liver disease (NAFLD) patients
by: Seyed Mostafa Arabi, et al.
Published: (2015-06-01)

IMPACT OF CURRENT DIET AT THE RISK OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
by: Sebastião Mauro Bezerra DUARTE, et al.
Published: (2019-11-01)

Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD)
by: Francesco Vizzutti;, et al.
Published: (2009-04-01)

Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
by: Pegah Golabi, et al.
Published: (2022-01-01)

Relative Recovery of Non-Alcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Rats
by: Hamda M. Aboujassoum, et al.
Published: (2023-12-01)

Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research
by: Christina-Maria Flessa, et al.
Published: (2022-12-01)

Obesity-related non-alcoholic fatty liver disease (NAFLD): a multifactorial process
by: Ángel Carazo, et al.
Published: (2014-12-01)

Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment
by: Xiangyu Guo, et al.
Published: (2022-12-01)

Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review
by: Kiarash Riazi, et al.
Published: (2022-10-01)

Non-alcoholic fatty liver disease (NAFLD) is associated with dynamic changes in DNA hydroxymethylation
by: Marcus J. Lyall, et al.
Published: (2020-02-01)

Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence
by: Arrigo F. G. Cicero, et al.
Published: (2018-08-01)

WHY DOES NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) CONTRIBUTE TO CARDIOVASCULAR OUTCOMES?
by: Hannele Yki-Järvinen
Published: (2016-11-01)

The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
by: Bengmark Stig, et al.
Published: (2010-04-01)